The Open UniversitySkip to content

Aptamers in oncology: a diagnostic perspective

Khan, Huma and Missailidis, Sotiris (2008). Aptamers in oncology: a diagnostic perspective. Gene Therapy and Molecular Biology, 12(A) pp. 111–128.

Full text available as:
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (850Kb)
Google Scholar: Look up in Google Scholar


Nucleic acid sequences can produce a wide variety of three-dimensional conformations. Some of these structural forms are able to interact with proteins and small molecules with high affinity and specificity. These sequences, comprising either double or single stranded oligonucleotides, are called 'aptamers' based on the Greek word aptus, which means 'to fit'. Using an efficient selection process, randomised oligonucleotide libraries can be rapidly screened for aptamers with the appropriate binding characteristics. This technology has spawned the development of a new class of oligonucleotide therapeutic products. However, while interest among pharmaceutical companies continues to grow with some candidates already in clinical trials and one in the market, there appears to be some reluctance to fully explore the diagnostic potential of this technology. This article will review aptamer developments in diagnostics, compare them with other oligonucleotide therapeutics and highlight both potentials and pitfalls of technological development in this area.

Item Type: Journal Article
Copyright Holders: 2008 Gene Therapy and Molecular Biology
ISSN: 1529-9120
Keywords: aptamers; diagnostics; oncology; aptazymes; aptasensors
Academic Unit/Department: Science > Life, Health and Chemical Sciences
Interdisciplinary Research Centre: Biomedical Research Network (BRN)
Item ID: 15255
Depositing User: Sotiris Missailidis
Date Deposited: 26 Jan 2011 16:27
Last Modified: 10 Mar 2014 13:22
Share this page:

Actions (login may be required)

View Item
Report issue / request change

Policies | Disclaimer

© The Open University   + 44 (0)870 333 4340